TET2 and cancer: In summary, by exploring the signaling pathways unique to HCC and absent from other types of cancer, we demonstrated, for the first time, that FGFR3∆7–9 phosphorylates the tumor suppressor TET2 at Y1902, which promotes TET2 ubiquitination and destruction.